The radiosensitizing effect of PARP inhibitors on human tumor cells was less pronounced than that on rodent tumor cells because of the longer accumulation of G2/M and G1 phases in human cells and the relatively shorter exposure of S-phase cells to radiation. Here, PARP1 is linked to neoplasm.